Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Benz

Showing results (331-340 of 489) with videos related to

Pageof 49
Sort By:
Archives of Biochemistry and Biophysics|January 27, 2025
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenaseKaylen R Meeks, Juan Ji, Gary K Scott, et al.
Oncotarget|November 16, 2017
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibitionGary K Scott, David Chu, Ravneet Kaur, et al.
Cancer Research|July 5, 2006
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsDmitri B Kirpotin, Daryl C Drummond, Yi Shao, et al.
International Journal of Cardiology|April 17, 2018
Impact of cardiac hybrid imaging-guided patient management on clinical long-term outcomeDominik C Benz, Lara Gaemperli, Christoph Gräni, et al.
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Molecular Cancer Therapeutics|June 14, 2019
Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase InhibitionGary K Scott, Christina Yau, Beatrice C Becker, et al.
Protein Engineering, Design & Selection : PEDS|January 5, 2018
Discovery of internalizing antibodies to basal breast cancer cellsYu Zhou, Hao Zou, Christina Yau, et al.
Gene Therapy|December 13, 2005
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene deliveryM E Hayes, D C Drummond, D B Kirpotin, et al.
Molecular Pharmacology|June 1, 1990
Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomersC C Benz, M A Keniry, J M Ford, et al.
Pageof 49

Showing results (331-340 of 489) with videos related to

Sort By:
Pageof 49
Archives of Biochemistry and Biophysics|January 27, 2025
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenaseKaylen R Meeks, Juan Ji, Gary K Scott, et al.
Oncotarget|November 16, 2017
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibitionGary K Scott, David Chu, Ravneet Kaur, et al.
Cancer Research|July 5, 2006
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsDmitri B Kirpotin, Daryl C Drummond, Yi Shao, et al.
International Journal of Cardiology|April 17, 2018
Impact of cardiac hybrid imaging-guided patient management on clinical long-term outcomeDominik C Benz, Lara Gaemperli, Christoph Gräni, et al.
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Molecular Cancer Therapeutics|June 14, 2019
Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase InhibitionGary K Scott, Christina Yau, Beatrice C Becker, et al.
Protein Engineering, Design & Selection : PEDS|January 5, 2018
Discovery of internalizing antibodies to basal breast cancer cellsYu Zhou, Hao Zou, Christina Yau, et al.
Gene Therapy|December 13, 2005
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene deliveryM E Hayes, D C Drummond, D B Kirpotin, et al.
Molecular Pharmacology|June 1, 1990
Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomersC C Benz, M A Keniry, J M Ford, et al.
Pageof 49